Energy News / Whistleblower Institute

$8 Million Settlement over a False Claims Act Allegations Against Omnicare Inc Announced by Whistleblower Institute

Via: ReleaseWire

Updated 9:30 AM CDT, Mon, September 11,2017

The Whistleblower Institute announces that Omnicare Inc reached an $8 million settlement in a False Claims Act lawsuit.

San Diego, CA -- (SBWIRE) -- 09/11/2017 -- The Whistleblower Institute announces that Omnicare Inc reached an $8 million settlement in a False Claims Act lawsuit filed by former employees over false claims being submitted to government healthcare programs.

Those who have a similar case or experienced a similar situation or any other wrongdoing within a corporation have certain options and should contact the Whistleblower Institute at mail@whistleblowerinstitute.com or call: 619-452–1218. There are no costs or obligations to you.

A settlement has been reached to resolve False Claims Act allegations against Omnicare Inc.

The allegations arose from a lawsuit that claimed Omnicare Inc submitted false claims for payment for drugs under the Medicare Part D and Medicaid programs from 2008 to 2014.

According to the government, Omnicare allegedly in an effort to increase business efficiency and profit, designed and implemented an automated label verification system at certain locations that used less specific drug codes than the National Drug Code that identifies the labeler, product and trade package size. The use of less specific drug codes resulted in Omnicare submitting claims to Medicare and Medicaid for generic drugs that were not actually dispensed to beneficiaries

Furthermore, the government alleged, the drugs being dispensed with patient-specific labels displayed an incorrect product identifier, affecting Omnicare's ability to conduct recalls.

"Ensuring accuracy in the dispensing of and billing for medication in the Medicare Part D and Medicaid Programs, especially to long-term care patients, is vital to public safety," Acting U.S. Attorney Fitzpatrick said.

Reportedly, the whistleblowers, former Omnicare pharmacists, Elizabeth Corsi and Christopher Ezzie, will receive more than $2 million as their share of the recovery and to resolve employment claims.

Omnicare is an American company working in the health care industry. In 2015, Omnicare was acquired by CVS Health.

The Whistleblower Institute is an information portal for current or former employees and other people having insight information about wrongdoing and other illegal activities by individuals either individually or within corporations, through company culture and or within international affairs. Whistleblowers should keep in mind that under the Dodd-Frank Act any person who provides the Securities and Exchange Commission ("SEC") with original information that leads to a successful enforcement action with over $1 million recovered must be awarded between 10%-30% of the total amount recovered. In order to determine the total amount of the reward there are numerous factors that need to be considered. Whistleblower actions are complex and our goal is to guide any whistleblower every step of the way. The Whistleblower Institute is dedicated to partnering with any individual who have information about fraud and we work with many of the best law firms worldwide.

Those who have a similar case or experienced a similar situation or any other wrongdoing within a corporation have certain options and should contact the Whistleblower Institute.

Contact:
Whistleblower Institute
2534 State Street - Suite 406
San Diego, CA 92101, USA
Phone: +1 (619) 452–1218
Facsimile: +1 (619) 785 – 3185
Email: mail@whistleblowerinstitute.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/8-million-settlement-over-a-false-claims-act-allegations-against-omnicare-inc-announced-by-whistleblower-institute-862236.htm

Media Relations Contact
Whistleblower Institute
619-452–1218
Email: Click to Email Whistleblower Institute
Web: http://www.whistleblowerinstitute.com